Skip to main content
Clinical Trials/CTRI/2023/10/058419
CTRI/2023/10/058419
Not yet recruiting
未知

A randomized, controlled, double blinded clinical study comparing neostigmine-glycopyrrolate and sugammadex in the reversal of rocuronium induced neuromuscular block in surgeries lasting 1 to 2 hours. - NI

SIMS hospitals, Department of anaesthesiology and pain management0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
SIMS hospitals, Department of anaesthesiology and pain management
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
SIMS hospitals, Department of anaesthesiology and pain management

Eligibility Criteria

Inclusion Criteria

  • ASA Grade 1 and 2, all patients willing to participate in the study who are undergoing surgery lasting 1 to 2 hours requiring general anaesthesia

Exclusion Criteria

  • ASA grade 3 and 4, BMI \> 30, deranged liver function, deranged renal function, anatomical malformations in airway, history of malignant hyperthermia, history of neuromuscular disorders, allergy to any general anaesthesia medications

Outcomes

Primary Outcomes

Not specified

Similar Trials